Decompressive Craniectomy in Patients With Cerebellar Infarction
NCT ID: NCT05670249
Last Updated: 2023-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2016-01-05
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decompressive Craniectomy In Malignant Middle Cerebral Artery Infarcts
NCT00190203
Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH
NCT02135783
The AGAINST Protocol: Augmentative Craniotomy in Stroke
NCT05860855
Hemicraniectomy in Patients With Malign Middle Cerebral Artery Infarction
NCT04555460
The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury
NCT00155987
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
surgical plus medical treatment
Decompressive surgery protocol was kept constant throughout the study period and defined the following surgical interventions: (1) extensive bilateral suboccipital decompresive craniectomy with duraplasty, optional resection of the posterior arch of atlas, (2) preceding insertion of an external ventricular drainage (EVD) in all cases, and (3) evacuation of necrotic tissue.
suboccipital decompressive craniectomy
extensive bilateral suboccipital decompressive craniectomy with duraplasty
conservative medical treatment
Control group (conservative medical) was treated equally aggressive with regard to intensive care measures. Medical management generally followed the Turkish and European guidelines on acute stroke care valid at the time of patient admission.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
suboccipital decompressive craniectomy
extensive bilateral suboccipital decompressive craniectomy with duraplasty
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Initial Glasgow Coma Scale (GCS) score \<9 on admission and clinical deterioration (a score of ≥ 1 decrease on GCS score) within 48 hours from onset.
* Decrease in the level of consciousness to a score of ≥ 1 on item 1a (level of consciousness) of the NIHSS, rapid deterioration to coma.
Exclusion Criteria
* Prestroke score on the Barthel Index \<95.
* Score on the Glasgow Coma Scale ≤6.
* Both pupils fixed and dilated.
* Any other coincidental brain lesion that might affect outcome.
* Space-occupying hemorrhagic transformation of the infarct.
* Pregnancy.
* Life expectancy \<3 years.
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Emre Kumral
Prof. Dr.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EU0691
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.